Screener
Gilead Sciences GILD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
Based on trailing twelve months.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's EBITDA margin?
- Gilead Sciences (GILD) reported EBITDA margin of 36.1% in Q1 2026.
- How has Gilead Sciences's EBITDA margin changed year-over-year?
- Gilead Sciences's EBITDA margin increased by 20.6% year-over-year, from 29.9% to 36.1%.
- What is the long-term trend for Gilead Sciences's EBITDA margin?
- Over 5 years (2020 to 2025), Gilead Sciences's EBITDA margin has grown at a 14.9% compound annual growth rate (CAGR), from 17.7% to 35.3%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Gilead Sciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude